NEALS Affiliated Trial Team Meeting
Amylyx A114-001 LUMINA Study
Amylyx A114-001 LUMINA Study
Session Leads: Jinsy Andrews, MD, MSc (New York University) and James Berry, MD, MPH (Sean M. Healey & AMG Center for ALS at Mass General) Speakers: Merit Cudkowicz, MD, MSc (Sean M. Healey & AMG Center for ALS at Mass General) Jeremy Shefner, MD, PhD (Barrow Neurological Institute) Presentation: ASO Therapies for ALS Timothy Miller, MD, PhD (Washington University in St. Louis)
Session Lead: Jinsy Andrews, MD, MSc (New York University) Presentations: Healey ALS MyMatch Program Update Suma Babu, MBBS, MPH (Sean M. Healey & AMG Center for ALS at Mass General) EPISOD1 study update on AMT-162 Gene Therapy for Individuals with SOD1 associated ALS George Apostol, MD (uniQure) Healey ALS Platform Trial - Adaptations and Next Regimens Merit Cudkowicz, MD, MSc (Sean M. Healey & AMG Center for ALS at Mass General) LUMINA Study Update Lauren Kett, MD, PhD (Amylyx Pharmaceuticals) and Sabrina Paganoni, MD, PhD (Sean M. Healey & AMG Center for ALS at Mass General) ALL ALS Study Update James Berry, MD, MPH (Sean M. Healey & AMG Center for ALS at Mass General) and Robert Bowser, PhD (Barrow Neurological Institute)
Clene NIH - Expanded Access Program Meeting
NEALS Member Registration Link here Dive into an enriching learning experience at the NEALS Cross-Committee Workshop, focusing on "Feeding Tubes and ALS: Multidisciplinary Practical Considerations." This hybrid workshop will unite leaders from the NEALS Palliative, Respiratory Care and Ventilation, Nutrition, and Bulbar Committees. Designed for NEALS members, the workshop aims to integrate expertise across these specialties, providing a comprehensive understanding of feeding tube management in ALS care. Through cross-disciplinary presentations, group Q&A, and interactive breakout sessions, participants will explore practical applications of feeding tubes, address procedural considerations, and discuss evidence-based best practices to enhance patient outcomes. This collaborative forum will foster cross-committee dialogue, bridging clinical practice with research to develop innovative solutions and improve patient outcomes. Don’t miss this opportunity to engage with peers and contribute to the future of ALS care.
LTX-002-101 NeurALS Study Update
Session Lead: Nicholas Maragakis, MD (Johns Hopkins University) Asa Abeliovich, MD PhD (Leal Therapeutics) Irina Antonijevic, MD, PhD (Trace Neuroscience) Ram Miller, MDCM, MS, FRCPC (Novartis) Shilpa Sambashivan, PhD (Nura Bio) Bernd-Jan Sanson, MD, PhD (Prilenia Therapeutics) Followed by moderated discussion and audience Q&A